A researcher demonstrates tumor-on-a-chip models that could enable personalized cancer treatment by testing drug responses in lab-grown mini-tumors.
Researcher demonstrates tumor-on-a-chip models
Stéphanie Descroix, a CNRS research director at the Curie Institute, shared a video on Instagram showcasing tumor-on-a-chip models, a cutting-edge technology used in biomedical research.Miniaturized devices mimic tumor environments
The technology uses small devices with reservoirs and chambers where cells can be placed. Microfluidics, a method for controlling and moving tiny amounts of liquid, helps circulate and organize these cells within the device.Recreating key tumor interactions
The goal is not to fully replicate an entire tumor but to recreate important aspects of its microenvironment. This includes interactions between tumor cells, immune cells, fibroblasts, and a collagen matrix that provides structural and mechanical signals to the cells.Process involves isolating and positioning cells
In the video, Descroix explained that researchers can break down a tumor, isolate different cell types, and place them in a collagen matrix that resembles spaghetti-like fibers. This setup mimics the complex structure found in real tumors.Technology holds promise for personalized medicine
The tumor-on-a-chip approach is considered a promising method for developing personalized treatments. However, it is still in the validation phase and is not yet used in standard medical practice for selecting treatments.Testing drug sensitivity in lab conditions
The technology allows scientists to test how these mini-tumor models respond to various drugs in the laboratory, potentially helping to identify the most effective treatments for individual patients.